Kiwi, If you want the company to make different decisions, talk to them. I can only track decisions that they make. How long did it take for statin drugs to gain traction? You apparently don't believe that the drug has clinical value. I do. Generic competition is forcing the price cuts. This is killing our margins and profit in the US. Is this a surprise for you? I believe both past and current management understand how to deal with this problem. Supply chain will be the key Once again I urge you to sell your position and move to a company that you can understand. Sleven,
Dear Kiwi, Every one agrees with all the concerns that you mentioned here in this post. No one is ignoring them.
What I don’t agree is you saying management is not doing anything to address it. And that they are just waiting and watching and in the interim their only plan is to use the $50Mil buy back to support the SP. That acquisition is as naive as it can get.
And of course you also know it very well that Amarin is not going to spend money to run another trial to revalidate reduce-it outcome, which you keep pushing for. Because that would be the most ridiculous thing for Amarin to do.
Market Data 
Markets 
AI
